Who owns MONTE ROSA THERAPEUTICS INC?
- Ticker: GLUE
- CUSIP Number: 61225m102
Tip: Access positions for across all investors
Analyze quarterly positions in Monte Rosa Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Monte Rosa Therapeutics stock
Who bought or sold MONTE ROSA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| NEA Management Company | 7.7M | $54M | 0% | Mar 2024 |
|
| FMR | 5.3M | $38M | -11% | Mar 2024 |
|
| T. Rowe Price Associates | 5.1M | $36M | 3% | Mar 2024 |
|
| Baker Bros. Advisors | 4.9M | $35M | 0% | Mar 2024 |
|
| venBio Select Advisor | 4.5M | $26M | 0% | Dec 2023 |
|
| BlackRock | 2.3M | $16M | -38% | Mar 2024 |
|
| Vanguard Group | 1.6M | $12M | 3% | Mar 2024 |
|
| Aisling Capital Management | 1.5M | $8.3M | 0% | Dec 2023 |
|
| Alphabet | 1.5M | $10M | 0% | Mar 2024 |
|
| Citadel Advisors | 997k | $7.0M | -4% | Mar 2024 |
|
| Geode Capital Management | 736k | $5.2M | 14% | Mar 2024 |
|
| Casdin Capital | 511k | $3.6M | 0% | Mar 2024 |
|
| Northern Trust | 291k | $2.0M | -35% | Mar 2024 |
|
| ExodusPoint Capital Management | 265k | $1.9M | -57% | Mar 2024 |
|
| Charles Schwab Investment Management | 251k | $1.8M | 2% | Mar 2024 |
|
| TD Asset Management | 193k | $1.4M | 0% | Mar 2024 |
|
| Millennium Management | 150k | $1.1M | 123% | Mar 2024 |
|
| Bank of New York Mellon | 94k | $663k | -6% | Mar 2024 |
|
| Nuveen Asset Management | 89k | $628k | -42% | Mar 2024 |
|
| Susquehanna International | 76k | $539k | 146% | Mar 2024 |
|
| Dimensional Fund Advisors | 73k | $512k | 199% | Mar 2024 |
|
| Sarasin & Partners | 65k | $459k | 0% | Mar 2024 |
|
| Bank of America Corporation | 62k | $438k | -23% | Mar 2024 |
|
| Morgan Stanley | 56k | $393k | 55% | Mar 2024 |
|
| Acadian Asset Management | 56k | $390k | 100% | Mar 2024 |
|
| State of Wisconsin Investment Board | 53k | $372k | 90% | Mar 2024 |
|
| Exchange Traded Concepts | 47k | $330k | 101% | Mar 2024 |
|
| Rhumbline Advisers | 47k | $328k | 3% | Mar 2024 |
|
| CornerCap Investment Counsel | 42k | $299k | 52% | Mar 2024 |
|
| UBS Group | 41k | $290k | 8% | Mar 2024 |
|
| Long Corridor Asset Management | 40k | $282k | 100% | Mar 2024 |
|
| American Century Companies | 34k | $239k | 71% | Mar 2024 |
|
| Alliancebernstein | 24k | $133k | 0% | Dec 2023 |
|
| Jane Street | 22k | $156k | -69% | Mar 2024 |
|
| Barclays | 22k | $154k | -65% | Mar 2024 |
|
| MetLife Investment Advisors | 18k | $103k | 0% | Dec 2023 |
|
| Legal & General Group | 16k | $111k | -22% | Mar 2024 |
|
| Goldman Sachs Group | 16k | $111k | -58% | Mar 2024 |
|
| Credit Suisse | 16k | $110k | -22% | Mar 2024 |
|
| American International | 15k | $86k | 0% | Dec 2023 |
|
| Florida State Board of Administration | 15k | $115k | -1% | Mar 2024 |
|
| PDT Partners | 14k | $98k | 100% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $94k | -4% | Mar 2024 |
|
| Wells Fargo & Company | 13k | $93k | 11% | Mar 2024 |
|
| Jpmorgan Chase & Co | 13k | $90k | -42% | Mar 2024 |
|
| New York State Common Retirement Fund | 12k | $86k | 0% | Mar 2024 |
|
| Mirae Asset Global Investments | 12k | $81k | 0% | Mar 2024 |
|
| Ing Investment Management | 11k | $74k | -89% | Mar 2024 |
|
| Citigroup | 5.9k | $42k | 34% | Mar 2024 |
|
| California State Teachers Retirement System | 3.1k | $22k | -93% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.1k | $21k | 100% | Mar 2024 |
|
| Summit Investment Advisors | 2.2k | $16k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.8k | $10k | 0% | Dec 2023 |
|
| Royal Bank of Canada | 1.2k | $9.4k | -89% | Mar 2024 |
|
| Amalgamated Bank | 995.00 | $7.0k | -64% | Mar 2024 |
|
| Brian McDonald | 841.00 | $5.9k | 100% | Mar 2024 |
|
| Tower Research Capital | 522.00 | $3.7k | -97% | Mar 2024 |
|
| Advisor Group Holdings | 400.00 | $2.8k | 0% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 300.00 | $2.1k | 0% | Mar 2024 |
|
| GAMMA Investing | 52.00 | $367.000400 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 13.00 | $91.999700 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 6.00 | $42.000000 | 100% | Mar 2024 |
|
| CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Monte Rosa Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Caption Management | Dec 2023 | 423k | $2.4M |
| Candriam Luxembourg S.C.A. | Dec 2023 | 135k | $763k |
| Hrt Financial | Dec 2023 | 63k | $357k |
| Sphera Funds Management | Dec 2023 | 49k | $274k |
| Balyasny Asset Management | Dec 2023 | 39k | $219k |
| Trexquant Investment | Sep 2023 | 26k | $123k |
| Squarepoint Ops | Dec 2023 | 18k | $99k |
| Verition Fund Management | Sep 2023 | 13k | $63k |
| SG Americas Securities | Dec 2023 | 12k | $69k |
| Cubist Systematic Strategies | Dec 2023 | 11k | $60k |
| Simplex Trading | Dec 2023 | 10k | $56k |
| Point72 Middle East FZE | Dec 2023 | 9.3k | $53k |